P
MRNA icon

Pitcairn’s Moderna MRNA Stock Holding History

Pitcairn’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,275
Closed -$229K – 617
2022
Q4 		$229K Buy
+1,275
New +$208K 0.02% 532
2022
Q3 		– Sell
-1,412
Closed -$202K – 590
2022
Q2 		$202K Buy
1,412
+32
+2% +$4.57K 0.02% 558
2022
Q1 		$238K Sell
1,380
-291
-17% -$49K 0.02% 551
2021
Q4 		$424K Sell
1,671
-1,141
-41% -$334K 0.03% 417
2021
Q3 		$1.08M Sell
2,812
-3,478
-55% -$1.28M 0.07% 191
2021
Q2 		$1.48M Buy
6,290
+4,612
+275% +$824K 0.1% 143
2021
Q1 		$219K Buy
+1,678
New +$243K 0.02% 569

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pitcairn's MRNA Position: Q1 2023 in Review

Pitcairn sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,275 shares — an estimated $229K sold.

Pitcairn first reported a position in MRNA in Q1 2021 and held it in 7 quarters. The position peaked at $1.48M in Q2 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Pitcairn reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Pitcairn sold 1,275 Moderna shares in Q1 2023, an estimated $229K.
  • Pitcairn first reported a position in Moderna in Q1 2021 and held it in 7 quarters.
  • Pitcairn's Moderna position peaked at $1.48M in Q2 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Pitcairn's 13F filing for Q1 2023, filed 5 May 2023.